From: MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
Factors | MTDH | |||
---|---|---|---|---|
Negative | Positive | Positive rate (%) | P value | |
Type | Â | Â | Â | 0.019c |
 Tumor | 15 | 22 | 59.46 |  |
 Peritumoral | 26 | 11 | 29.73 | |
Age(year) | Â | Â | Â | 0.315c |
  < 40 | 5 | 11 | 68.75 |  |
  ≥ 40 | 10 | 11 | 52.38 |  |
Grade | Â | Â | Â | 1.000c |
 I | 1 | 1 | 50.00 |  |
 II | 11 | 14 | 56.00 |  |
 III | 2 | 4 | 66.67 |  |
 Unknown | 1 | 3 |  |  |
TNM stage | Â | Â | Â | 0.627c |
 I/II/III | 13 | 17 | 56.67 |  |
 IV | 1 | 4 | 80.00 |  |
 Unknown | 1 | 1 |  |  |
Node status | Â | Â | Â | Â |
 Positive | 9 | 19 | 67.86 | 0.090c |
 Negative | 5 | 2 | 28.57 |  |
 Unknown | 1 | 1 |  |  |
Histopathological subtype | Â | Â | Â | 1.000c |
 Ductal carcinoma | 14 | 19 | 57.58 |  |
 Lobular carcinoma | 1 | 1 | 50.00 |  |
 Others | 0 | 1 | 100.00 |  |
 Unknown | 0 | 1 |  |  |